Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Cancers|June 2, 2021
The Ratio of GrzB<sup>+</sup> - FoxP3<sup>+</sup> over CD3<sup>+</sup> T Cells as a Potential Predictor of Response to Nivolumab in Patients with Metastatic MelanomaGiosuè Scognamiglio, Mariaelena Capone, Francesco Sabbatino, et al.Oncoimmunology|August 2, 2014
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapyAntonio M Grimaldi, Ester Simeone, Diana Giannarelli, et al.Cancers|August 27, 2021
Clinical Categorization Algorithm (CLICAL) and Machine Learning Approach (SRF-CLICAL) to Predict Clinical Benefit to Immunotherapy in Metastatic Melanoma Patients: Real-World Evidence from the Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, ItalyGabriele Madonna, Giuseppe V Masucci, Mariaelena Capone, et al.Journal of Translational Medicine|June 3, 2014
Discrepant alterations in main candidate genes among multiple primary melanomasMaria Colombino, MariaCristina Sini, Amelia Lissia, et al.Journal of Translational Medicine|February 24, 2023
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimabDomenico Mallardo, Ester Simeone, Lucia Festino, et al.Journal of Translational Medicine|September 30, 2022
Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarizationDomenico Mallardo, Ester Simeone, Vito Vanella, et al.The Oncologist|December 21, 2023
Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go?Salvatore Alfieri, Rebecca Romanò, Sara Marceglia, et al.Journal for Immunotherapy of Cancer|August 14, 2020
Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in ItalyVincenzo Montesarchio, Roberto Parrela, Chiara Iommelli, et al.Cancer Immunology, Immunotherapy : CII|April 4, 2014
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanomaEster Simeone, Giusy Gentilcore, Diana Giannarelli, et al.Biology|August 27, 2021
Clinical Outcome Prediction in COVID-19 Patients by Lymphocyte Subsets Analysis and Monocytes' iTNF-α ExpressionGabriele Madonna, Silvia Sale, Mariaelena Capone, et al.Pageof 4